
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Clinical Profile and Prognosis of Hereditary Transthyretin Amyloid Cardiomyopathy: A Single-Center Study in South China - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="8E59B808926007933AB808000E587F72.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="fcvm">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9271707/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Frontiers in Cardiovascular Medicine">
<meta name="citation_title" content="Clinical Profile and Prognosis of Hereditary Transthyretin Amyloid Cardiomyopathy: A Single-Center Study in South China">
<meta name="citation_author" content="Shuai Wang">
<meta name="citation_author_institution" content="Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author" content="Wenke Peng">
<meta name="citation_author_institution" content="Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author" content="Min Pang">
<meta name="citation_author_institution" content="Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author" content="Ling Mao">
<meta name="citation_author_institution" content="Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author" content="Daoquan Peng">
<meta name="citation_author_institution" content="Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author" content="Bilian Yu">
<meta name="citation_author_institution" content="Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author" content="Sha Wu">
<meta name="citation_author_institution" content="Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author" content="Die Hu">
<meta name="citation_author_institution" content="Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author" content="Yang Yang">
<meta name="citation_author_institution" content="Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author" content="Jia He">
<meta name="citation_author_institution" content="Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_author" content="Mingqi Ouyang">
<meta name="citation_author_institution" content="Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China">
<meta name="citation_publication_date" content="2022 Jun 27">
<meta name="citation_volume" content="9">
<meta name="citation_firstpage" content="900313">
<meta name="citation_doi" content="10.3389/fcvm.2022.900313">
<meta name="citation_pmid" content="35833187">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9271707/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9271707/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9271707/pdf/fcvm-09-900313.pdf">
<meta name="description" content="Hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) is a genotypically heterogeneous disorder with a poor prognosis. There is limited literature describing the variants responsible for ATTRv in areas outside the United State, the United ...">
<meta name="og:title" content="Clinical Profile and Prognosis of Hereditary Transthyretin Amyloid Cardiomyopathy: A Single-Center Study in South China">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) is a genotypically heterogeneous disorder with a poor prognosis. There is limited literature describing the variants responsible for ATTRv in areas outside the United State, the United ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9271707/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="9271707">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3389/fcvm.2022.900313"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/fcvm-09-900313.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9271707%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/9271707/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/9271707/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9271707/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-fcvm.gif" alt="Frontiers in Cardiovascular Medicine logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Frontiers in Cardiovascular Medicine" title="Link to Frontiers in Cardiovascular Medicine" shape="default" href="http://www.frontiersin.org/Cardiovascular_Medicine" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Front Cardiovasc Med</button></div>. 2022 Jun 27;9:900313. doi: <a href="https://doi.org/10.3389/fcvm.2022.900313" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3389/fcvm.2022.900313</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Front%20Cardiovasc%20Med%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Front%20Cardiovasc%20Med%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Front%20Cardiovasc%20Med%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Front%20Cardiovasc%20Med%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Clinical Profile and Prognosis of Hereditary Transthyretin Amyloid Cardiomyopathy: A Single-Center Study in South China</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Shuai Wang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Shuai Wang</span></h3>
<div class="p">
<sup>1</sup>Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shuai Wang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Peng%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Wenke Peng</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Wenke Peng</span></h3>
<div class="p">
<sup>1</sup>Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Peng%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wenke Peng</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pang%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Min Pang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Min Pang</span></h3>
<div class="p">
<sup>1</sup>Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pang%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Min Pang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mao%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Ling Mao</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Ling Mao</span></h3>
<div class="p">
<sup>1</sup>Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mao%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Ling Mao</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Peng%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Daoquan Peng</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Daoquan Peng</span></h3>
<div class="p">
<sup>1</sup>Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Peng%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Daoquan Peng</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Bilian Yu</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Bilian Yu</span></h3>
<div class="p">
<sup>1</sup>Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Bilian Yu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Sha Wu</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Sha Wu</span></h3>
<div class="p">
<sup>1</sup>Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sha Wu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hu%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Die Hu</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Die Hu</span></h3>
<div class="p">
<sup>1</sup>Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hu%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Die Hu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Yang Yang</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Yang Yang</span></h3>
<div class="p">
<sup>1</sup>Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yang Yang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22He%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Jia He</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Jia He</span></h3>
<div class="p">
<sup>1</sup>Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22He%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jia He</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ouyang%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Mingqi Ouyang</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Mingqi Ouyang</span></h3>
<div class="p">
<sup>1</sup>Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ouyang%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mingqi Ouyang</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China</div>
<div class="author-notes p">
<div class="fn" id="fn1"><p>Edited by: Jeffrey Shi Kai Chan, Cardiovascular Analytics Group, Hong Kong SAR, China</p></div>
<div class="fn" id="fn2"><p>Reviewed by: Concetta Zito, University of Messina, Italy; Marcus V. Pinto, Mayo Clinic, United States</p></div>
<div class="fn" id="c001">
<sup>✉</sup><p class="display-inline">*Correspondence: Daoquan Peng <span>pengdq@csu.edu.cn</span></p>
</div>
<div class="fn" id="fn001"><p>This article was submitted to Heart Failure and Transplantation, a section of the journal Frontiers in Cardiovascular Medicine</p></div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2022 Mar 20; Accepted 2022 Jun 7; Collection date 2022.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2022 Wang, Peng, Pang, Mao, Peng, Yu, Wu, Hu, Yang, He and Ouyang.</div>
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC9271707  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35833187/" class="usa-link">35833187</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p>Hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) is a genotypically heterogeneous disorder with a poor prognosis. There is limited literature describing the variants responsible for ATTRv in areas outside the United State, the United Kingdom and Europe. This study was performed to describe the clinical characteristics and genotypic profiles of this disease in South China.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p>This was a single-center retrospective study that evaluated 29 patients with a confirmed diagnosis of hereditary transthyretin amyloid cardiomyopathy enrolled from January 2016 to November 2021.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p>93.1% patients were male and the median age of symptom onset was 53 (46, 62.5) years old. The initial manifestations of ATTR-CM were cardiovascular symptoms (55.2%), neuropathy (41.4%) and vitreous opacity (3.4%). Phenotypes at diagnosis were mixed (82.8%), predominant cardiac (6.9%), neurological (6.9%) and ophthalmic (3.4%). Poor R-wave progression (41%), pseudo-infarct (31%) and low-voltage (31%) patterns were common findings on electrocardiogram. Unexplained increased wall thickness was observed in all 29 patients, with mean septal and posterior wall thicknesses of 14.25 ± 6.26 mm and 15.34 ± 2.84 mm, respectively. Diastolic dysfunction was also seen in all 29 patients, and 17 (58%) had a restrictive fill pattern at diagnosis. Nine different missense mutations of the TTR gene were found in 29 patients from 23 families, with c.349G&gt;T (p.Ala117Ser) the most common mutation. The median survival time after diagnosis was 47.6 (95% CI 37.9-57.4) months, with 1, 3 and 5-year survival rates of 91.2%, 74% and 38% respectively. Patients with advanced heart failure (National Amyloidosis Staging stage II/III) had worse survival than stage I [Breslow (Generalized Wilcoxon), χ2 = 4.693, <em>P</em> = 0.03)].</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions</h3>
<p>ATTR amyloidosis genotypes and phenotypes are highly heterogeneous. Advanced heart failure predicts a poor prognosis. Understanding the different clinical profiles of ATTR cardiac amyloidosis with different genotype is important to its early recognition.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> hereditary, transthyretin amyloidosis, cardiomyopathy, prognosis, China</p></section></section><section id="s1"><h2 class="pmc_sec_title">Introduction</h2>
<p>Hereditary transthyretin amyloidosis (ATTRv) represents a group of severe diseases with a broad spectrum of genotypes and phenotypes caused by transthyretin (TTR) gene mutations. ATTR is the result of dissociation of the transthyretin tetramer into monomers that mis-fold, forming amyloid deposits in the extracellular space (<a href="#B1" class="usa-link" aria-describedby="B1">1</a>). The most common manifestations of ATTR are polyneuropathy and cardiomyopathy (<a href="#B2" class="usa-link" aria-describedby="B2">2</a>). As our understanding of the molecular mechanisms behind ATTR amyloidosis improves, disease-modifying treatments including stabilizing molecular (tafamidis) and genetic silencers (partisiran and inotersen) have been made available. As pharmacotherapy is more effective in the early stages of the disease, the early diagnosis of ATTR by understanding its genotype-phenotype correlations is important (<a href="#B3" class="usa-link" aria-describedby="B3">3</a>–<a href="#B5" class="usa-link" aria-describedby="B5">5</a>).</p>
<p>More than 120 mutations of the TTR gene have been described, and as of December 2021 there are 68 pathogenic/likely pathogenic variants of the TTR gene listed in the National Center for Biotechnology Information ClinVar database (<a href="#B6" class="usa-link" aria-describedby="B6">6</a>–<a href="#B8" class="usa-link" aria-describedby="B8">8</a>). Some genotype-phenotype variability has been reported. Although the THAOS registry collected ATTR phenotypes and genotypes from continental Western Europe and the United States, few studies have been performed in China. Two recent retrospective cohort studies revealed that the mutation of TTR in Chinese patients may be quite different from that seen in the United States and Europe (<a href="#B9" class="usa-link" aria-describedby="B9">9</a>, <a href="#B10" class="usa-link" aria-describedby="B10">10</a>). Further, those two studies mainly discussed ATTRv patients from northern China and one study focused on ATTRv patients with neuropathy as main symptom. Here, we report the phenotype and genotype of 29 patients with ATTRv cardiomyopathy (ATTRv-CM) from 23 unrelated South Chinese families.</p></section><section id="s2"><h2 class="pmc_sec_title">Methods</h2>
<section id="sec7"><h3 class="pmc_sec_title">Study Design and Population</h3>
<p>This was a descriptive, observational, and retrospective study that included patients diagnosed with hereditary ATTRv-CM at our institution from January 2016 to November 2021. The study was undertaken in accordance with the Declaration of Helsinki and was approved by the ethics committee of Second Xiangya Hospital. Due to the retrospective nature of this study, informed consent was waived for patients who had died. Otherwise, all patients provided written informed consent.</p></section><section id="sec8"><h3 class="pmc_sec_title">Diagnosis of Hereditary ATTR Cardiac Amyloidosis</h3>
<p>The diagnosis of hereditary ATTRv-CM was established by clinical presentation, family history, echocardiography, tissue biopsy and DNA sequencing for the presence of a mutation in the TTR gene. Cardiac magnetic resonance (CMR) and <sup>99m</sup>technetium (<sup>99m</sup>Tc)-pyrophosphate (PYP) scintigraphy were performed in select cases. All included patients had a positive tissue biopsy (endocardium or extracardiac, e.g., abdominal adipose tissue or vitreous body) for amyloidosis and a pathogenic/likely pathogenic TTR variant. Light chain amyloidosis was ruled out by confirming a normal free light chain ratio and the absence of detectable serum and/or urine monoclonal protein. Patients without a related gene mutation on TTR gene sequencing were excluded.</p>
<p>The date of symptom onset was reported by the patient as the date on which symptoms related to amyloidosis first were noted. The date of diagnosis was the date on which the diagnosis of amyloidosis was confirmed histologically.</p>
<p>Phenotype categories based on clinical presentation at the time of diagnosis were: 1) predominantly cardiac. 2) predominantly neurological. 3) mixed (cardiac and neurological); and 4) ophthalmic. Patients with a predominantly cardiac phenotype were those (1) with heart failure, dyspnea and/or abnormal electrocardiogram findings caused by rhythm disturbance and (2) who did not have more than mild neurological or gastrointestinal symptoms (excluding erectile dysfunction, constipation and carpal tunnel syndrome). Patients with a predominantly neurologic phenotype were those with (1) walking disability of any severity, other neurologic symptoms of any severity or gastrointestinal symptoms (early satiety, nausea, vomiting, unintentional weight loss, diarrhea, constipation or fecal incontinence) of any severity and (2) who did not have heart failure, dyspnea, or an abnormal ECG due to a rhythm disturbance. Patients with a (3) mixed phenotype were patients who had at least 1 cardiac and neurological symptom as described above. Patients with (4) an ophthalmic phenotype had vitreous opacity with none of the cardiac or neurological symptoms described above.</p>
<p>Cardiomyopathy was defined as an end-diastolic thickness of the left ventricular wall &gt; 1.2 cm (in the absence of any other plausible causes of LV hypertrophy). Other clues suggestive of cardiac amyloidosis included granular sparkling appearance of the ventricular myocardium, increased thickness of the atrioventricular valves or the interatrial septum and reduced tissue doppler e' velocities. CMR and <sup>99m</sup>Tc-PYP were performed in select cases. Characteristic CMR findings of (1) the inability to suppress or “null” the myocardial signal or (2) the presence of diffuse subendocardial or transmural enhancement patterns on late gadolinium enhancement CMR were recorded. Grade 2 or 3 cardiac uptake on <sup>99m</sup>Tc-PYP scintigraphy was also recorded.</p>
<p>N-terminal pro-B type natriuretic peptide (NT-proBNP), estimated glomerular filtration rate (eGFR), cardiac troponin (cTnT), modified poly neuropathy disability (PND) score and the U.K. National Amyloidosis Staging (NAC) and New York Heart Association (NYHA) stages were recorded. NAC Stage I is defined as NT-proBNP ≤ 3000 ng/L and eGFR ≥ 45 mL/min, and NAC stage III was defined as NT-proBNP&gt; 3000 ng/L and eGFR &lt; 45 mL/min. The remainder of the patients were assigned to NAC stage II.</p></section><section id="sec9"><h3 class="pmc_sec_title">Neurological Work-Up</h3>
<p>Neurological examination included an assessment of motor, cerebellar and reflex function as well as screening for sensory function. Muscle strength was documented according to the Medical Research Council (MRC) scale (5/5 normal strength, 0/5 no contractions). Motor and sensory nerve conduction studies were performed on patients with reported neurologic symptoms. The PND score was used to stage patients with ATTRv and polyneuropathy at baseline. PND I was defined as sensory disturbances in the extremities but preserved walking capacity; PND II was defined as difficulty walking but without the need for a walking stick; PND III was defined as sticks or crutches required for walking; and PND IV was defined as confined to a wheelchair or bed.</p></section><section id="sec10"><h3 class="pmc_sec_title">Genetic Testing of the TTR Gene</h3>
<p>Genomic DNA was isolated from whole peripheral blood using standard techniques. Exon 1–4 of the <em>TTR</em> gene were amplified with polymerase chain reaction. Sequences of the <em>TTR</em> gene (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000371.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000371.3</a>; <a href="https://www.ncbi.nlm.nih.gov/nuccore/NG_009490.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NG_009490.1</a>) were analyzed using the Applied BioSystems SeqScape software v4.0 (Carlsbad, USA) and the DNA Dynamo Sequence Analysis Software (North Wales, UK). The datasets presented in this study can be found in an online repository. The name of the repository and its accession numbers can be found in the supplementary material (<a href="#SM1" class="usa-link">Supplementary Table 1</a>). Genetic testing and clinical penetrance assessments were performed on family members for probands if available.</p></section><section id="sec11"><h3 class="pmc_sec_title">Follow-Up</h3>
<p>Patient follow-ups at 6 to 12-month intervals included an ECG, NT-proBNP and yearly echocardiogram. Mutation carriers were surveilled via regular (yearly) telephone contact.</p></section><section id="sec12"><h3 class="pmc_sec_title">Statistical Analyses</h3>
<p>Continuous variables are reported as mean ± SD or median and interquartile range (IQR) (for non-normal distributions). Categorical variables are reported as percentages. Kaplan-Meier survival was calculated from the date of the original diagnosis to the date of death or the most recent contact. Gehan-Breslow-Wilcoxon method was used to compare survival curves. All tests were 2-tailed and a <em>P</em>-value &lt;0.05 was considered statistically significant. Statistical analyses were performed using SPSS Statistics (version 26. IBM Corp., Chicago, IL, USA).</p></section></section><section id="s3"><h2 class="pmc_sec_title">Results</h2>
<section id="sec14"><h3 class="pmc_sec_title">Clinical Characteristics of Patients With ATTR Cardiac Amyloidosis</h3>
<p>The clinical characteristics at diagnosis of the 29 patients are summarized in <a href="#T1" class="usa-link">Tables 1</a>, <a href="#T2" class="usa-link">2</a>. Twenty-seven (93.1%) patients were male. The median age at symptom onset was 53 (46, 62.5) years and the median age at diagnosis was 56 (47.75–66.25) years. The median time from symptom onset to diagnosis was 24 (12−24) months and the median course from diagnosis to the last visit was 15 (6.5–37.5) months.</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Clinical Manifestations of ATTRv-CM and the <em>TTR</em> variant Ala97Ser.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th rowspan="1" colspan="1"></th>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>All (<em>n</em> = 29)</strong>
</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>Ala97Ser (<em>n</em> = 11)</strong>
</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>Non Ala97Ser (<em>n</em> = 18)</strong>
</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong><em>p</em>-value</strong>
</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>General characteristics</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Male, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">27 (93.1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">10 (91)</td>
<td valign="top" align="center" rowspan="1" colspan="1">17 (89.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.702</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Age of symptom onset, y</td>
<td valign="top" align="center" rowspan="1" colspan="1">53 (46–62.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">65 (62–66)</td>
<td valign="top" align="center" rowspan="1" colspan="1">50 (45–58.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Age at diagnosis, y</td>
<td valign="top" align="center" rowspan="1" colspan="1">56 (47.8–66.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">68 (64–72.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">50.5 (46.8–59.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Time from symptom onset to diagnosis, m</td>
<td valign="top" align="center" rowspan="1" colspan="1">24 (12–48)</td>
<td valign="top" align="center" rowspan="1" colspan="1">48 (24–102)</td>
<td valign="top" align="center" rowspan="1" colspan="1">24 (13–45)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.084</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Course from diagnosis to last visit, m</td>
<td valign="top" align="center" rowspan="1" colspan="1">15 (6.5–37.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">13 (8–30)</td>
<td valign="top" align="center" rowspan="1" colspan="1">19 (5.75–45.75)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.65</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Initial presentation</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Neuropathy as initial presentation, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">12 (41.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">11 (100)</td>
<td valign="top" align="center" rowspan="1" colspan="1">15 (83.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.27</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Cardiovascular symptom as initial presentation, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">16 (55.2)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">16 (88.9)</td>
<td valign="top" align="center" rowspan="1" colspan="1">&lt;0.001</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Vitreous opacity, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (3.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (5.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Clinical presentation at diagnosis</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">HF, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">23 (79.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">8 (72.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">15 (88.2)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.35</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">NYHA stage, <em>n</em> (%)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> I</td>
<td valign="top" align="center" rowspan="1" colspan="1">7 (24.1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (27)</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (36.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.65</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> II</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (3.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (9.1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.38</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> III</td>
<td valign="top" align="center" rowspan="1" colspan="1">14 (48.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5 (45.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">9 (52.9)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">7 (24.1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (18.2)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5 (29.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.68</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Typical echocardiography at diagnosis, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">29 (100)</td>
<td valign="top" align="center" rowspan="1" colspan="1">11 (100)</td>
<td valign="top" align="center" rowspan="1" colspan="1">19 (100)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Abnormal ECG, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">15 (51.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5 (45.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">10 (55.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.71</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">NAC staging score, <em>n</em> (%)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Stage I</td>
<td valign="top" align="center" rowspan="1" colspan="1">21 (67.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">8 (72.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">12 (70.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Stage II</td>
<td valign="top" align="center" rowspan="1" colspan="1">6 (19.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (27.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (17.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.65</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Stage III</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (12.9)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (11.8)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.51</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Somatic neuropathy, <em>n</em> (%)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> (Diarrhea, Constipation, Orthostatic hypotension, Upper</td>
<td valign="top" align="center" rowspan="1" colspan="1">14 (48.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">6 (54.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">8 (47.1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.70</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> gastrointestinal tract symptoms, eg. early satiety, dyspepsia,</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> dysphagia, vomiting)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Peripheral neuropathy, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">25 (86.2)</td>
<td valign="top" align="center" rowspan="1" colspan="1">11 (100)</td>
<td valign="top" align="center" rowspan="1" colspan="1">14 (82.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.26</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> History of Carpal tunnel syndrome, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">6 (20.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (18.2)</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (23.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.73</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Lumber Spinal stenosis, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (3.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (9.1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.38</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">PND score at diagnosis</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> 0</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (12.9)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (22.2)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.27</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> I</td>
<td valign="top" align="center" rowspan="1" colspan="1">8 (25.8)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (9.1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">7 (38.9)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.11</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> II</td>
<td valign="top" align="center" rowspan="1" colspan="1">9 (29)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (27.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">6 (35.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.001</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> III</td>
<td valign="top" align="center" rowspan="1" colspan="1">7 (22.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">6 (54.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (5.9)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.006</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (9.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (9.1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (11.8)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.14</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Phenotype</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Predominantly cardiac, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (6.9)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (11.1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.51</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Predominantly neurological, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (6.9)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (9)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (5.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Mixed, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">24 (82.8)</td>
<td valign="top" align="center" rowspan="1" colspan="1">10 (91)</td>
<td valign="top" align="center" rowspan="1" colspan="1">14 (77.8)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.62</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Ocular, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (3.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (5.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Patients receiving tafamidis, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (9.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (25%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (5.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.14</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p22"><p><em>Values are mean ± SD, n (%), or median (25th to 75th percentile). HF, heart failure; NYHA, New York Heart Association; NAC, National Amyloidosis Staging; PND, polyneuropathy disability</em>.</p></div></div></section><section class="tw xbox font-sm" id="T2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Complementary baseline tests for ATTRv–CM and the <em>TTR</em> variant Aal97Ser.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th rowspan="1" colspan="1"></th>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>All (<em>n</em> = 29)</strong>
</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>Aal97Ser (<em>n</em> = 11)</strong>
</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>Non–Ala97Ser (<em>n</em> = 18)</strong>
</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong><em>p</em>–value</strong>
</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Biomarkers</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">NT–proBNP, pg/ml</td>
<td valign="top" align="center" rowspan="1" colspan="1">2789 (1206–5024)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2081 (973–3706.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2722 (1425–5245)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.30</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">cTnT, pg/ml</td>
<td valign="top" align="center" rowspan="1" colspan="1">61.5 (42.8–88.9)</td>
<td valign="top" align="center" rowspan="1" colspan="1">45.5 (42.1–73.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">85.3 (27.7–125.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.41</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">eGFR, ml/min/1.73 m<sup>2</sup>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">81.7 (66.4–93.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">90 (83.7–95.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">79.3 (64.5–94.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.16</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Electrocardiogram</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Atrial fibrillation/flutter, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (25)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.51</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">AV block, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5 (17)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5 (27.8)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.13</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">RBBB/LBBB, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (10)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (9.1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (25)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Pacemaker, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (25)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.51</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">LV hypertrophy (Sokolow), <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Low voltage</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Classic criteria<sup>a</sup>, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">9 (31)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5 (45.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (22)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.24</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1"> Sokolow<sup>b</sup>, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">8 (58)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (27.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5 (27.8)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Pseudo–infarct pattern, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">9 (31)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (27.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">6 (33.3))</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Poor Precordial R wave progression, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">12 (41)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5 (45.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">7 (38.9)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Echocardiography</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">LVH, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">29 (100)</td>
<td valign="top" align="center" rowspan="1" colspan="1">11 (100)</td>
<td valign="top" align="center" rowspan="1" colspan="1">18 (100)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">LVEF &lt;50%, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (6.8)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (9.1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (5.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">LV diastolic dysfunction, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">29 (100)</td>
<td valign="top" align="center" rowspan="1" colspan="1">11 (100)</td>
<td valign="top" align="center" rowspan="1" colspan="1">18 (100)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Restrictive filling (e' &lt;5 cm/s)</td>
<td valign="top" align="center" rowspan="1" colspan="1">17 (58)</td>
<td valign="top" align="center" rowspan="1" colspan="1">6 (54.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">11 (61.1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Pericardial effusion, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">9 (31)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (27.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">6 (33.3)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">LVIDd, mm</td>
<td valign="top" align="center" rowspan="1" colspan="1">47.74 ± 5.37</td>
<td valign="top" align="center" rowspan="1" colspan="1">43.16 ± 3.18</td>
<td valign="top" align="center" rowspan="1" colspan="1">43.33 ± 4.50</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.99</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">IVS thickness, mm</td>
<td valign="top" align="center" rowspan="1" colspan="1">16.39 ± 3.04</td>
<td valign="top" align="center" rowspan="1" colspan="1">15.83 ± 4.26</td>
<td valign="top" align="center" rowspan="1" colspan="1">17.00 ± 2.60</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.59</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">PWT, mm</td>
<td valign="top" align="center" rowspan="1" colspan="1">15.34 ± 2.84</td>
<td valign="top" align="center" rowspan="1" colspan="1">14.50 ± 2.26</td>
<td valign="top" align="center" rowspan="1" colspan="1">17.00 ± 2.61</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.08</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Left atrial size, mm</td>
<td valign="top" align="center" rowspan="1" colspan="1">39.47 ± 5.54</td>
<td valign="top" align="center" rowspan="1" colspan="1">38.83 ± 5.51</td>
<td valign="top" align="center" rowspan="1" colspan="1">43.50 ± 4.46</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.68</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">LVEF, %</td>
<td valign="top" align="center" rowspan="1" colspan="1">52.65 ± 10.65</td>
<td valign="top" align="center" rowspan="1" colspan="1">55.17 ± 13.87</td>
<td valign="top" align="center" rowspan="1" colspan="1">49.83 ± 5.12</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.70</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">PA systolic pressure, mm Hg</td>
<td valign="top" align="center" rowspan="1" colspan="1">33.36(26.16–35.18)</td>
<td valign="top" align="center" rowspan="1" colspan="1">32.00 (26.16–34.59)</td>
<td valign="top" align="center" rowspan="1" colspan="1">28.00 (24.36–30.00)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.37</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">e' average, cm/s</td>
<td valign="top" align="center" rowspan="1" colspan="1">4.64 ± 1.11</td>
<td valign="top" align="center" rowspan="1" colspan="1">5.33 ± 1.25</td>
<td valign="top" align="center" rowspan="1" colspan="1">4.07 ± 0.62</td>
<td valign="top" align="center" rowspan="1" colspan="1">0.05</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Cardiac magnetic resonance at diagnosis</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">
<em><strong>n</strong></em>
<strong>=</strong>
<strong>17</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">
<em><strong>n</strong></em>
<strong>=</strong>
<strong>5</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">
<em><strong>n</strong></em>
<strong>=</strong>
<strong>12</strong>
</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Inability to suppress or “null” the myocardial signal, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">17 (100)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5 (100)</td>
<td valign="top" align="center" rowspan="1" colspan="1">12 (100)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Diffuse subendocardial/transmural enhancement pattern, <em>n</em> (%)</td>
<td valign="top" align="center" rowspan="1" colspan="1">17 (100)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5 (100)</td>
<td valign="top" align="center" rowspan="1" colspan="1">12 (100)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<strong>Cardiac uptake grading in</strong>
<sup><strong>99m</strong></sup><strong>Tc–PYP scintigraphy at diagnosis</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">
<em><strong>n</strong></em>
<strong>=</strong>
<strong>9</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">
<em><strong>n</strong></em>
<strong>=</strong>
<strong>5</strong>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">
<em><strong>n</strong></em>
<strong>=</strong>
<strong>4</strong>
</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Grade 0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Grade 1</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Grade 2</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (22.2)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (20)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (25)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Grade 3</td>
<td valign="top" align="center" rowspan="1" colspan="1">7 (77.8)</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (80)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (75)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1.0</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="_fn_p24"><p><em>Values are mean ± SD, n (%), or median (25th to 75th percentile). NT–proBNP, N–terminal pro–B type natriuretic peptide; cTnT, cardiac troponin; eGFR, estimated glomerular filtration rate; AV, atrioventricular; RBBB, right bundle branch block; LBBB: left bundle branch block; LV, left ventricular; LVH, left ventricular hypertrophy; LVEF, left ventricular ejection fraction; LVIDd, left ventricular internal diameter at end–diastole; IVS, interventricular septum; PWT, posterior wall thickness; PA, pulmonary artery</em>.</p></div>
<div class="fn" id="TN1"><p><em><sup>a</sup> &lt;0.5 mV in all limb leads or &lt; 1.0 mV in all precordial leads</em>.</p></div>
<div class="fn" id="TN2"><p><em><sup>b.</sup>sum of S in V1 and R in V5/V6 &lt; 25mm</em>.</p></div>
</div></section><p>Dyspnea on exertion and limited physical capacity were the initial complaints that prompted a comprehensive cardiological examination in 16 cases (55.2%). Another 12 (41.4%) patients presented with distal sensory disturbances and/or weakness predominantly of the lower limbs. One patient reported vitreous opacity as their initial manifestation and had asymptomatic cardiac hypertrophy at diagnosis.</p>
<p>Twenty-four (82.8%) patients presented with a mixed phenotype that included both cardiomyopathy and neuropathy, while 2 (6.9%) had a predominantly cardiac phenotype and 2 (6.9%) had a predominantly neurological phenotype. One patient (3.4%) presented with vitreous opacity with asymptomatic myocardial hypertrophy. Peripheral and autonomic nerve dysfunction were found in 25 (86.2%) and 14 (48.3%) subjects at diagnosis, respectively. Six patients (20.7%) had a history of uni- or bilateral carpal tunnel syndrome. Lumber spinal stenosis was reported in one patient. The PND score was used to describe the severity of the peripheral neuropathy (<a href="#T1" class="usa-link">Table 1</a>). At diagnosis, 72.4% (21) had severe heart failure (NYHA III/IV), 3.4% (1) had mild heart failure (NYHA II) and 24.1% (7) had asymptomatic myocardial hypertrophy (<a href="#T1" class="usa-link">Table 1</a>). Elevated NT-proBNP and cTnT were found in 29 (100%) and 28 (97%) patients, respectively. The median NT-proBNP and cTnT levels were 2789 (1206–5024) pg/ml and 61.5 (42.8–88.9) pg/ml at diagnosis. Only one patient had an eGFR &lt;45 and the median eGFR was 81.7 (66.4–93.6) ml/min/1.73 m<sup>2</sup> (<a href="#T2" class="usa-link">Table 2</a>). Of the 29 patients, 19 (65.6%) were NAC stage I, 9 (31%) stage II and 1 (3.4%) stage III.</p>
<p>Electrocardiogram abnormalities were evident in 15 (51.7%) patients at diagnosis. Two (6.9%) had atrial fibrillation, 5 (17.2%) presented with an atrial-ventricular block and 2 went on to require a permanent pacemaker. The classic low-voltage pattern of ATTR-CM was found in 9 (31%) patients, while a low-voltage pattern according to the Sokolow criteria was found in 8 (27.5%). A pseudo-infarct pattern was found in 9 (31%) patients and poor R wave progression was found in 12 (41%, <a href="#T2" class="usa-link">Table 2</a>).</p>
<p>Unexplained increased wall thickness (&gt;12 mm) and diastolic dysfunction were observed in 29 (100%) patients. Two (6.9%) had systolic dysfunction with an ejection fraction &lt;50%. Restrictive filling (e' &lt;5 cm/s) was present in 17 (58%) patients at diagnosis. Pericardial effusions were present in 9 patients (31%). The mean septal and posterior wall thicknesses of the cohort were 16.39±3.04 mm and 15.34±2.84 mm, respectively, and the mean systolic left atrial diameter was 39.47±5.54 mm. The mean LVEF was 52.65±10.6%. CMR was performed on 16 (55.2%) patients to diagnose ATTR cardiac amyloidosis, all of which showed diffuse subendocardial or transmural LGE and abnormal gadolinium kinetics. <sup>99m</sup>TC-PYP scintigraphy was performed on 9 patients (31%). Seven had grade 3 cardiac uptake and 2 patients had grade 2 uptake. Biopsies were performed on all patients, and originated from the abdominal fat (28), endomyocardium (1) or vitreous body (1) (<a href="#T2" class="usa-link">Table 2</a>). All samples were positive on Congo red staining and TTR immunochemistry. Four patients (9.5%) in this cohort were on tafamidis post-enrollment, and no patient received a liver transplant.</p></section><section id="sec15"><h3 class="pmc_sec_title">Genetic Spectrum of TTR Mutations</h3>
<p>Genetic testing of the probands and their family members identified 9 different missense <em>TTR</em> mutations [Asp18Asn(p.Asp38Asn), Ser23Asn(p.Ser43Asn), Glu42Gly (p.Glu62Gly), Gly47Glu(p.Gly67Glu), Leu55Arg(p.Leu75Arg), Thr59Lys(p.Thr79Lys), Glu61Lys(p.Glu81Lys), His108Arg (p.His108Arg), Ala97Ser(p.Ala117Ser)] and 1 small deletion mutation (3'UTR c.624_632 del GACTTCTCC) in 29 patients from 23 families. Pedigree analysis found another 11 asymptomatic mutation carriers without electrocardiographic and echocardiographic abnormalities. The predominant genotypes identified in ATTR-CA were the Ala97Ser (p.Ala117Ser) mutation (11/29, 37.9%) followed by Thr59Lys (p.Thr79Lys) (5, 17.2%) (<a href="#F1" class="usa-link">Figure 1</a>). Of these variants, Asp18Asn, Ser23Asn, Glu42Gly, Gly47Glu, Thr59Lys, Glu61Lys, His88Arg and Ala97Ser were associated with the mixed phenotype while Leu55Arg was associated with the ophthalmic phenotype. The deletion mutation was found in a patient with a cardiac phenotype (<a href="#T3" class="usa-link">Table 3</a>).</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9271707_fcvm-09-900313-g0001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8422/9271707/27c78b3509b5/fcvm-09-900313-g0001.jpg" loading="lazy" height="649" width="708" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Distribution of <em>TTR</em> mutations in a cohort of ATTR-CA patients from South China.</p></figcaption></figure><section class="tw xbox font-sm" id="T3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Genotype distribution in probands and family members.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong><em>TTR</em> mutation</strong>
</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>Overall <em>N = 40, n (%)</em></strong>
</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>Symptomatic patients <em>N = 29, n (%)</em></strong>
</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>Associated phenotype in the cohort</strong>
</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">A97S</td>
<td valign="top" align="center" rowspan="1" colspan="1">16 (40)</td>
<td valign="top" align="center" rowspan="1" colspan="1">11 (37.9)</td>
<td valign="top" align="center" rowspan="1" colspan="1">N, H</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">D18N</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (10)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (10.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">N, H</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">E42G</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (2.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (3.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">N, H</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">E61K</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (2.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (3.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">N, H</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">G47E</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (2.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (3.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">N, H</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">H88R</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (2.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (3.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">N, H</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">L55R</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (2.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (3.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">E, H</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">S23N</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (10)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (3.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">N, H</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">T59K</td>
<td valign="top" align="center" rowspan="1" colspan="1">8 (20)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5 (17.2)</td>
<td valign="top" align="center" rowspan="1" colspan="1">N, H</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Exon3 3'UTR c.624_632delGACTTCTCC</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (2.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (3.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">H</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p34"><p><em>N, neurological; H, Heart; E, eye</em>.</p></div></div></section><p>Ala97Ser was the most common mutation in this cohort. 72.7% (8/11 cases) of patients carrying the Ala97Ser presented with evidence of heart failure at confirmed diagnosis of ATTRv cardiac amyloidosis, with 63.7% (7/11) having NYHAIII/IV (<a href="#T1" class="usa-link">Table 1</a>). All patients with Ala97Ser mutations initially presented with neurological dysfunction, but cardiac symptoms followed 2–9 years later. The median age of onset of neurological symptom related to ATTR amyloidosis in patients carrying the Ala97Ser variant was 65 (62–67) years old and the median time from neurological symptom onset to diagnosis of ATTRv-CM was 48 (24–102) months.</p></section><section id="sec16"><h3 class="pmc_sec_title">Survival</h3>
<p>During January 2016 to November 2021, 29 patients were diagnosed with hereditary ATTRv-CM and followed up at our institution. The date when symptoms related to ATTRv began, (which was 30 (12, 54) months before diagnosis of ATTR-CM), was recorded according to the patient's report. The mortality rate of the cohort over a median follow-up of 14 (5.75, 32.25) months was 7/29 (24%). The estimated median survival times after initial symptom onset related to ATTRv and at confirmed diagnosis of ATTRv-CM by Kaplan-Meier survival curve analysis were 131 (95%CI 88.6–173.7) and 47.6 (95%CI 37.9–57.4) months, respectively. According to Kaplan-Meier survival curve analysis, the estimated 3-, 5- and 10-year survival rates after symptom onset were 90%, 70% and 52.6%, respectively (<a href="#F2" class="usa-link">Figure 2A</a>). The overall 1-year survival rate after diagnosis was 91.2%, and the 3- and 5-year survival rates were 74% and 38%, respectively (<a href="#F2" class="usa-link">Figure 2B</a>).</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9271707_fcvm-09-900313-g0002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8422/9271707/d1c4b829424d/fcvm-09-900313-g0002.jpg" loading="lazy" height="317" width="708" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>(A)</strong> Kaplan-Meier survival curves of data obtained from ATTR-CA symptom onset. Overall survival at 12-, 36-, 60-, and 120- months after symptom onset were 100%, 90%, 70% and 52.6%, respectively. Numbers below the plot represent the number of subjects at risk at each time point. Cumulative events refer to all-cause death. The median survival time after symptom onset was 131 (95%CI 88.6–173.7) months. <strong>(B)</strong> Kaplan-Meier survival curves at confirmed diagnosis. Overall survival at 12-, 36-, and 60- months was 91.2%, 74%, and 38% respectively. Numbers below the plot represent the number of subjects at risk at each time point. Cumulative events refer to all-cause death. The estimated median survival time after confirmed diagnosis of ATTRv-CM was 47.6 (95%CI 37.9–57.4) months.</p></figcaption></figure><p>For patient carrying Ala97Ser variant, survival curve analysis revealed the estimated mean survival time after symptom onset and at diagnosis were 181(95%CI 120.2, 241.8) months and 38.5 (95%CI 30.9, 46.1) months. Patient with other variants had estimated mean survival time of 102 (95%CI 73.1, 132.1) months after symptom onset and 43.9 (95%CI 31.3, 56.4) months at diagnosis. Cumulative survival rate at 150 months after symptom onset was 66.7% in Ala97Ser and 0% in other variants. The difference in survival curve for Ala97Ser and other variants at symptom onset was not significant [Breslow (Generalized Wilcoxon), χ2 = 2.92, <em>p</em> = 0.087] (<a href="#F3" class="usa-link">Figure 3A</a>). No significant difference was found in survival curve between patient carrying Ala97Ser and other variants at confirmed diagnosis. [Breslow (Generalized Wilcoxon), χ2 = 0.859, <em>p</em> = 0.35] (<a href="#F3" class="usa-link">Figure 3B</a>).</p>
<figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9271707_fcvm-09-900313-g0003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8422/9271707/f91d1445e7fd/fcvm-09-900313-g0003.jpg" loading="lazy" height="554" width="708" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>(A)</strong> Comparison of Kaplan-Meier survival curves of data obtained from ATTR-CA symptom onset between patients with Ala97Ser and other variants. There was no significant difference in survival in patients with Ala97Ser and other variants [Breslow (Generalized Wilcoxon), χ2 = 2.92, <em>p</em> = 0.087]. <strong>(B)</strong> Comparison of Kaplan-Meier survival curves at confirmed diagnosis between patients with Ala97Ser and other variants. Survival after diagnosis was not significantly different in patients with Ala97Ser and other variants [Breslow (Generalized Wilcoxon), χ2 = 0.859, <em>p</em> = 0.35]. <strong>(C)</strong> Kaplan-Meier survival curve for patients grouped by NAC stage at diagnosis. Patients with NAC stage II/III disease had worse survival than those with NAC stage I disease [Breslow (Generalized Wilcoxon), χ2 = 4.693, <em>p</em> = 0.03)]. The median survival time of patients in NAT stage I was 48 months (95%CI 39–63) and the cumulative survival at 60 months was 46.7%. The median survival time of patients in NAC stage II/III was 33 months (95%CI 13.7–55.3) and the cumulative survival at 60 months was 0%.</p></figcaption></figure><p>Patient at an early disease stage (NAC stage I) tended to have a lower mortality rate, with a median survival time of 48 months (95%CI 39–63 month) and a cumulative survival rate at 60 months of 46.7% [Breslow (Generalized Wilcoxon), χ2 = 4.693, <em>p</em> = 0.03]. In contrast, the median survival time of patients at a later disease stage (NAC II, III) was 33 months (95%CI 13.7–55.3), with a cumulative survival rate at 60 months of 0% (<a href="#F3" class="usa-link">Figure 3C</a>) All deaths were observed in patients with NYHA III-IV heart failure.</p></section></section><section id="s4"><h2 class="pmc_sec_title">Discussion</h2>
<p>Male predominance (93%) was observed in this cohort, which was higher than previous reports on ATTRv-CM whose samples were approximately 70% (<a href="#B11" class="usa-link" aria-describedby="B11">11</a>–<a href="#B13" class="usa-link" aria-describedby="B13">13</a>). This may be due to the small sample size of this study. The underlying mechanism for male predominance is unclear. The small sample size of women did not permit summarization of the sex-related clinical characteristics of ATTRv-CM. However, a recent systematic literature review on sex-related differences in transthyretin amyloid cardiomyopathy revealed that women tended to have lower interventricular septal and posterior wall thicknesses, smaller left ventricular end diastolic diameters and a higher LV ejection fraction. It was postulated that the disparity in the incidence of ATTRv-CM between sexes may be due to either the cardioprotective effects of estrogen or sex-related differences in clinical presentation or disease characteristics (<a href="#B11" class="usa-link" aria-describedby="B11">11</a>).</p>
<p>A mixed phenotype was most common presentation in this cohort (82.8%), while a predominantly cardiac phenotype and neurological phenotype was seen in 6.9% of patients each. ATTRv phenotype is associated with <em>TTR</em> mutations. While some mutations are associated with a predominantly cardiac phenotype, others are primarily related to a neurological phenotype. Previously reported common cardiac mutations (Val122Ile, leu111Met, Thr60Alr, Ile68Leu) in ATTRv were not identified in our cohort (<a href="#B14" class="usa-link" aria-describedby="B14">14</a>). However, we found that non-cardiac mutations such as Asp18Asn, Ser23Asn, Glu42Gly, Gly47Glu, Thr59Lys, Glu61Lys, His88Arg and Ala97Ser were associated with a cardiac phenotype with or without neurologic symptoms. These differences in genotype-phenotype relationship may be the result of their diagnosis at different disease stages.</p>
<p>Ten different <em>TTR</em> gene mutations, including 9 missense variants and 1 small deletion mutation, were identified. All of the missense variants have been listed as pathogenic or likely pathogenic in the TTR mutation and ClinVar databases (<a href="#T4" class="usa-link">Table 4</a>) (<a href="#B15" class="usa-link" aria-describedby="B15">15</a>–<a href="#B23" class="usa-link" aria-describedby="B23">23</a>). The missense mutations were related to the mixed phenotype. Glu61Lys, which was previously found to cause ATTR neuropathy, had never been reported in ATTR-CM. The cardiac mutations Asp18Asn and His68Arg also caused neuropathy in our study. The small deletion <em>TTR</em> mutation (c.624_632delGACTTCTCC) was located outside the coding region in exon 3 of the <em>TTR</em> gene. As the patient's family history could not be collected due to the limited medical records of the deceased parents, it could not be excluded that this variant of unknown significance occurred by chance in a patient with wild-type ATTR.</p>
<section class="tw xbox font-sm" id="T4"><h3 class="obj_head">Table 4.</h3>
<div class="caption p"><p>Bioinformatic results of the identified missense <em>TTR</em> mutations.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>Sequence variant (mRNA)</strong>
</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>Mutation (protein variant incl.20–aa signal peptide)</strong>
</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>Location</strong>
</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>ClinVar</strong>
</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>Reported phenotype</strong>
</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>Reported ethnic group</strong>
</th>
<th valign="top" align="left" rowspan="1" colspan="1">
<strong>References</strong>
</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">c.112G&gt;A</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.Asp38Asn (Asp18Asn)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Exon 2</td>
<td valign="top" align="left" rowspan="1" colspan="1">Likely pathogenic</td>
<td valign="top" align="left" rowspan="1" colspan="1">H</td>
<td valign="top" align="left" rowspan="1" colspan="1">American</td>
<td valign="top" align="left" rowspan="1" colspan="1">Connors et al. (<a href="#B15" class="usa-link" aria-describedby="B15">15</a>) Amyloid 10, 160</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">c.128G&gt;A</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.Ser43Asn (Ser23Asn)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Exon 2</td>
<td valign="top" align="left" rowspan="1" colspan="1">Likely pathogenic</td>
<td valign="top" align="left" rowspan="1" colspan="1">E, H, PN</td>
<td valign="top" align="left" rowspan="1" colspan="1">Portuguese, American</td>
<td valign="top" align="left" rowspan="1" colspan="1">Connors et al. (<a href="#B16" class="usa-link" aria-describedby="B16">16</a>) Amyloid 6, 114</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">c.185A&gt;G</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.Glu62Gly (Glu42Gly)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Exon 2</td>
<td valign="top" align="left" rowspan="1" colspan="1">pathogenic</td>
<td valign="top" align="left" rowspan="1" colspan="1">SN, H, PN</td>
<td valign="top" align="left" rowspan="1" colspan="1">Japanese, Russian, American</td>
<td valign="top" align="left" rowspan="1" colspan="1">Ueno et al. (<a href="#B17" class="usa-link" aria-describedby="B17">17</a>) Biochem Biophys Res Commun 169, 1117</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">c.200G&gt;A</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.GLy67Glu (Gly47Glu)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Exon 2</td>
<td valign="top" align="left" rowspan="1" colspan="1">pathogenic</td>
<td valign="top" align="left" rowspan="1" colspan="1">H, K, PN</td>
<td valign="top" align="left" rowspan="1" colspan="1">German, Italian</td>
<td valign="top" align="left" rowspan="1" colspan="1">Pelo et al. (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>) Amyloid 9, 35</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">c.224T&gt;G</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.Leu75Arg (Leu55Arg)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Exon 3</td>
<td valign="top" align="left" rowspan="1" colspan="1">pathogenic</td>
<td valign="top" align="left" rowspan="1" colspan="1">LM, PN, E</td>
<td valign="top" align="left" rowspan="1" colspan="1">Chinese, German</td>
<td valign="top" align="left" rowspan="1" colspan="1">Long et al. (<a href="#B19" class="usa-link" aria-describedby="B19">19</a>) Ophthalmic Genet 33(1):28–33 Connors (2003) Amyloid 10, 160</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">c.236C&gt;A</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.Thr79Lys (Thr59Lys)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Exon 3</td>
<td valign="top" align="left" rowspan="1" colspan="1">Likely pathogenic</td>
<td valign="top" align="left" rowspan="1" colspan="1">SN, H, PN</td>
<td valign="top" align="left" rowspan="1" colspan="1">Italian, American (Asian)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Saraiva et al. (<a href="#B20" class="usa-link" aria-describedby="B20">20</a>) Hum Mutat 5, 191</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">c.241G&gt;A</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.Glu81Lys (Glu61Lys)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Exon 3</td>
<td valign="top" align="left" rowspan="1" colspan="1">Pathogenic</td>
<td valign="top" align="left" rowspan="1" colspan="1">PN</td>
<td valign="top" align="left" rowspan="1" colspan="1">Japanese</td>
<td valign="top" align="left" rowspan="1" colspan="1">Shiomi et al. (<a href="#B21" class="usa-link" aria-describedby="B21">21</a>) Biochem Biophys Res Commun 194, 1090</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">c.323A&gt;G</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.His108Arg (His88Arg)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Exon 3</td>
<td valign="top" align="left" rowspan="1" colspan="1">Pathogenic</td>
<td valign="top" align="left" rowspan="1" colspan="1">H</td>
<td valign="top" align="left" rowspan="1" colspan="1">Swedish</td>
<td valign="top" align="left" rowspan="1" colspan="1">Holmgren et al. (<a href="#B22" class="usa-link" aria-describedby="B22">22</a>) Amyloid 12, 184</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">c.349G&gt;T</td>
<td valign="top" align="left" rowspan="1" colspan="1">p.Ala117Ser (Ala97Ser)</td>
<td valign="top" align="left" rowspan="1" colspan="1">Exon 4</td>
<td valign="top" align="left" rowspan="1" colspan="1">Pathogenic</td>
<td valign="top" align="left" rowspan="1" colspan="1">PN, H, E, SN</td>
<td valign="top" align="left" rowspan="1" colspan="1">Chinese, Taiwanese</td>
<td valign="top" align="left" rowspan="1" colspan="1">Tachibana et al. (<a href="#B23" class="usa-link" aria-describedby="B23">23</a>) Amyloid 6, 282</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p45"><p><em>H, heart; PN, peripheral neuropathy; SN, Somatic neuropathy; E, eye; K, kidney; LM, lumber stenosis</em>.</p></div></div></section><p>In this study, 10 different mutations (<em>n</em> = 40) have been identified in probands and family members, with the most common being Ala97Ser (<em>n</em> = 16; 40%). In addition, Ala97Ser is the most common mutation in symptomatic patient (<em>n</em> = 11;37.9%). This was different in the United States, where Val1122Ile (p.Val142Ile) and Thr60Ala (p.T80A) were the most common mutations (<a href="#B14" class="usa-link" aria-describedby="B14">14</a>). In European countries, Val30Met was the most frequent mutation in subjects with ATTR in the THAOS registry, followed by Ile68Leu (<a href="#B12" class="usa-link" aria-describedby="B12">12</a>). This discrepancy may reflect the heterogeneity of ATTR genotypes between different countries. Ala97Ser has been previously found to be a common ATTR mutation in cohorts of Chinese patients with predominant neurologic phenotypes, including patients from north China and Taiwan. It has also been reported in Chinese Malaysians (<a href="#B10" class="usa-link" aria-describedby="B10">10</a>, <a href="#B24" class="usa-link" aria-describedby="B24">24</a>–<a href="#B27" class="usa-link" aria-describedby="B27">27</a>). (<a href="#SM2" class="usa-link">Supplementary Table 2</a>) Similar with previous studies, male predominance was observed in Ala97Ser. Consistant with other studies, our study found that all patients with Ala97Ser initially presented with a predominantly neurologic phenotype in the early stages of disease. However, the proportion of patients developing cardiomyopathy as the disease progressed was higher (72.7%) than previous reports. Most Ala97Ser patients exhibited a mixed phenotype at their time of diagnosis in our study, which suggests that diagnosis was delayed until a late disease stage. This may be attributed to the difficulty with diagnosing ATTR in patients with isolated peripheral neuropathy symptoms, especially when reg flag symptoms such as carpal tunnel syndrome and lumber stenosis were rarely presented in this cohort. In this situation, family history and genetic examination were important to the early diagnosis of an ATTR patient with a neurological phenotype. On the other hand, CMR and <sup>99m</sup>Tc-PYP scintigraphy may help to identify myocardial involvement in patients who does not report symptom of heart failure due to limited physical activity caused by neuropathy.</p>
<p>Survival is poor in patients with ATTR cardiac amyloidosis. Although survival varies by genotype, phenotype, and disease stage, most series have reported a median survival of 2.5–3.5 years for patients with heart failure (<a href="#B8" class="usa-link" aria-describedby="B8">8</a>). There was a poorer prognosis in the present work for subjects with more severe heart failure, with a 5 year survival rate of &lt;20% for those with NYHA III-IV disease. Several studies have noted the prognostic role of NT-proBNP (<a href="#B28" class="usa-link" aria-describedby="B28">28</a>). The NAC staging system includes NT-proBNP and eGFR and has a good prognostic accuracy (<a href="#B29" class="usa-link" aria-describedby="B29">29</a>). Patients with advanced NAC stage (stage 2, 3) had a poor prognosis (median survival: 34.5 months, 3-year survival rate: 43%). More advanced NYHA classification at diagnosis also tended to predict a poor prognosis, although there was no statistical significance due to the limited sample size of our study. Phenotype, genotype, initial manifestation and severity of peripheral neuropathy as shown by PND score were not predictive in our study.</p>
<p>The natural average life expectancy is 9 to 13 years after the symptom onset and death usually results from cardiac involvement and cachexia (<a href="#B30" class="usa-link" aria-describedby="B30">30</a>). As disease modifying therapy, liver transplantation has been demonstrated to prolong survival. However, the statistics are mostly related to patients with ATTR V30M (<a href="#B31" class="usa-link" aria-describedby="B31">31</a>), which was not identified in our study cohort. Different from previous two cohort studies in China, no patient received liver transplantation in our cohort because the following reasons 1) For patients with advanced heart failure, liver transplantation does not provide a complete cure for the disease due to the newly formed amyloid around the preexisting amyloid seeds (<a href="#B32" class="usa-link" aria-describedby="B32">32</a>). Combining liver and heart transplantation may be a better strategy. 2) Liver transplantation is restricted by the availability of transplant organs as well as the advanced age and comorbidities of ATTR-CM patients. 3) The need for life-long immunosuppression therapy.</p>
<p>Tafamidis, a small molecule that inhibits the dissociation of transthyretin tetramers, was granted marketing authorization by China Food and Drug Administration for the treatment of inherited or wild type cardiac transthyretin amyloidosis in adult patients in 2020. However, only a few patients could afford this disease modifying therapy because the price of tafamidis was expensive (64,100<img class="inline" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8422/9271707/9a8ab5967647/fcvm-09-900313-i0001.jpg" loading="lazy" alt="Inline graphic">/month in 2020, then reduced to 24,650<img class="inline" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8422/9271707/9a8ab5967647/fcvm-09-900313-i0001.jpg" loading="lazy" alt="Inline graphic">/month in 2021). Up to November 2021, only 9.5% (<a href="#B4" class="usa-link" aria-describedby="B4">4</a>) patients received tafamidis in our cohort. Fortunately, more patients will have chance to receive this disease modifying therapy since National Health Insurance Administration has issued a national coverage decision to incorporate Tafamidis into medical insurance payouts in 2022.</p>
<p>There are several limitations to our study. First, this was a retrospective study that included a limited sample size. Second, all probands were admitted to our cardiology department first, which results in selection bias that may not permit the description of the actual phenotype-genotype relationship. Third, nuclear scintigraphy was only used in 9 (31%) patients. Expanding the sample size and long-term follow-up of the proband patients and their genotype positive phenotype negative pedigree is needed to understand the relationship between ATTRv genotype and disease course.</p></section><section id="s5"><h2 class="pmc_sec_title">Conclusion</h2>
<p>Hereditary ATTRv-CM has heterogeneous phenotypes and genotypes. Most patients had a mixed phenotype that included both cardiomyopathy and neuropathy. Ala97Ser, the most common mutation in South China, initially presented as peripheral and automatic neuropathy and progressed to heart failure at a later disease stage. The prognosis of ATTR was poor, and patients with NYHA III-IV and NAC stage 3 had the worst prognosis.</p></section><section id="s6"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The original contributions presented in the study are included in the article/<a href="#SM1" class="usa-link">Supplementary Materials</a>, further inquiries can be directed to the corresponding author.</p></section><section id="s7"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>The studies involving human participants were reviewed and approved by the Ethics Committee of Second Xiangya Hospital. The patients/participants provided their written informed consent to participate in this study.</p></section><section id="s8"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>SW wrote the protocol, evaluated cardiac involvement, analyzed the results and wrote the manuscript. WP and MP collected the data. LM did the TTR sequencing and analyzed the gene data. DP conceived of the study. BY revised the manuscript and provided guidance for the study. SW, BY, DP, SW, DH, YY, and JH evaluated the patients and made the clinical diagnosis for each patient. All authors contributed to the article and approved the submitted version.</p></section><section id="s9"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported by grants from the National Nature Science Foundation Youth Project (81600359) and the National Nature Science Foundation General Project (81870336).</p></section><section id="conf1"><h2 class="pmc_sec_title">Conflict of Interest</h2>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></section><section id="s10"><h2 class="pmc_sec_title">Publisher's Note</h2>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We would like to thank all of the participating families and investigators for their important contributions to this study. Additional investigators contributing to analysis Na Liu.</p></section><section id="s11"><h2 class="pmc_sec_title">Supplementary Material</h2>
<p>The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fcvm.2022.900313/full#supplementary-material" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.frontiersin.org/articles/10.3389/fcvm.2022.900313/full#supplementary-material</a></p>
<section class="sm xbox font-sm" id="SM1"><div class="media p"><div class="caption">
<a href="/articles/instance/9271707/bin/Table_1.DOCX" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (15.6KB, DOCX) </sup>
</div></div></section><section class="sm xbox font-sm" id="SM2"><div class="media p"><div class="caption">
<a href="/articles/instance/9271707/bin/Table_2.DOCX" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (15.2KB, DOCX) </sup>
</div></div></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. (2016) 387:2641–54. 10.1016/S0140-6736(15)01274-X</cite> [<a href="https://doi.org/10.1016/S0140-6736(15)01274-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26719234/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet.&amp;title=Systemic%20amyloidosis&amp;author=AD%20Wechalekar&amp;author=JD%20Gillmore&amp;author=PN%20Hawkins&amp;volume=387&amp;publication_year=2016&amp;pages=2641-54&amp;pmid=26719234&amp;doi=10.1016/S0140-6736(15)01274-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>Koike H, Okumura T, Murohara T, Katsuno M. Multidisciplinary approaches for transthyretin amyloidosis. Cardiol Ther. (2021) 10:289–311. 10.1007/s40119-021-00222-w</cite> [<a href="https://doi.org/10.1007/s40119-021-00222-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8177037/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34089151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiol%20Ther.&amp;title=Multidisciplinary%20approaches%20for%20transthyretin%20amyloidosis&amp;author=H%20Koike&amp;author=T%20Okumura&amp;author=T%20Murohara&amp;author=M%20Katsuno&amp;volume=10&amp;publication_year=2021&amp;pages=289-311&amp;pmid=34089151&amp;doi=10.1007/s40119-021-00222-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. (2018) 379:1007–16. 10.1056/NEJMoa1805689</cite> [<a href="https://doi.org/10.1056/NEJMoa1805689" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30145929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med.&amp;title=Tafamidis%20treatment%20for%20patients%20with%20transthyretin%20amyloid%20cardiomyopathy&amp;author=MS%20Maurer&amp;author=JH%20Schwartz&amp;author=B%20Gundapaneni&amp;author=PM%20Elliott&amp;author=G%20Merlini&amp;volume=379&amp;publication_year=2018&amp;pages=1007-16&amp;pmid=30145929&amp;doi=10.1056/NEJMoa1805689&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>Benson MD, Waddington-Cruz M, Berk JL, Polydefkis M, Dyck PJ, Wang AK, et al. Inotersen treatment for patients with hereditary transthyretin amyloidosis. N Engl J Med. (2018) 379:22–31. 10.1056/NEJMoa1716793</cite> [<a href="https://doi.org/10.1056/NEJMoa1716793" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12611561/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29972757/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med.&amp;title=Inotersen%20treatment%20for%20patients%20with%20hereditary%20transthyretin%20amyloidosis&amp;author=MD%20Benson&amp;author=M%20Waddington-Cruz&amp;author=JL%20Berk&amp;author=M%20Polydefkis&amp;author=PJ%20Dyck&amp;volume=379&amp;publication_year=2018&amp;pages=22-31&amp;pmid=29972757&amp;doi=10.1056/NEJMoa1716793&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>Adams D, Gonzalez-Duarte A, O'Riordan WD, Yang CC, Ueda M, Kristen AV, et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med. (2018) 379:11–21. 10.1056/NEJMoa1716153</cite> [<a href="https://doi.org/10.1056/NEJMoa1716153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29972753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med.&amp;title=Patisiran,%20an%20RNAi%20therapeutic,%20for%20hereditary%20transthyretin%20amyloidosis&amp;author=D%20Adams&amp;author=A%20Gonzalez-Duarte&amp;author=WD%20O'Riordan&amp;author=CC%20Yang&amp;author=M%20Ueda&amp;volume=379&amp;publication_year=2018&amp;pages=11-21&amp;pmid=29972753&amp;doi=10.1056/NEJMoa1716153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. (2018) 46:D1062–D7. 10.1093/nar/gkx1153</cite> [<a href="https://doi.org/10.1093/nar/gkx1153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5753237/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29165669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=ClinVar:%20improving%20access%20to%20variant%20interpretations%20and%20supporting%20evidence&amp;author=MJ%20Landrum&amp;author=JM%20Lee&amp;author=M%20Benson&amp;author=GR%20Brown&amp;author=C%20Chao&amp;volume=46&amp;publication_year=2018&amp;pages=D1062-D7&amp;pmid=29165669&amp;doi=10.1093/nar/gkx1153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>Carry BJ, Young K, Fielden S, Kelly MA, Sturm AC, Avila JD, et al. Genomic screening for pathogenic transthyretin variants finds evidence of underdiagnosed amyloid cardiomyopathy from health records. JACC CardioOncol. (2021) 3:550–61. 10.1016/j.jaccao.2021.07.002</cite> [<a href="https://doi.org/10.1016/j.jaccao.2021.07.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8543083/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34746851/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JACC%20CardioOncol.&amp;title=Genomic%20screening%20for%20pathogenic%20transthyretin%20variants%20finds%20evidence%20of%20underdiagnosed%20amyloid%20cardiomyopathy%20from%20health%20records&amp;author=BJ%20Carry&amp;author=K%20Young&amp;author=S%20Fielden&amp;author=MA%20Kelly&amp;author=AC%20Sturm&amp;volume=3&amp;publication_year=2021&amp;pages=550-61&amp;pmid=34746851&amp;doi=10.1016/j.jaccao.2021.07.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>Ruberg FL, Berk JL. Transthyretin (TTR) cardiac amyloidosis. Circulation. (2012) 126:1286–300. 10.1161/CIRCULATIONAHA.111.078915</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.111.078915" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3501197/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22949539/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation.&amp;title=Transthyretin%20(TTR)%20cardiac%20amyloidosis&amp;author=FL%20Ruberg&amp;author=JL%20Berk&amp;volume=126&amp;publication_year=2012&amp;pages=1286-300&amp;pmid=22949539&amp;doi=10.1161/CIRCULATIONAHA.111.078915&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>He S, Tian Z, Guan H, Li J, Fang Q, Zhang S. Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy. Orphanet J Rare Dis. (2019) 14:251. 10.1186/s13023-019-1235-x</cite> [<a href="https://doi.org/10.1186/s13023-019-1235-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6852775/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31718691/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20J%20Rare%20Dis.&amp;title=Clinical%20characteristics%20and%20prognosis%20of%20Chinese%20patients%20with%20hereditary%20transthyretin%20amyloid%20cardiomyopathy&amp;author=S%20He&amp;author=Z%20Tian&amp;author=H%20Guan&amp;author=J%20Li&amp;author=Q%20Fang&amp;volume=14&amp;publication_year=2019&amp;pages=251&amp;pmid=31718691&amp;doi=10.1186/s13023-019-1235-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>Du K, Li F, Wang H, Miao Y, Lv H, Zhang W, et al. Hereditary transthyretin amyloidosis in mainland China: a unicentric retrospective study. Ann Clin Transl Neurol. (2021) 8:831–41. 10.1002/acn3.51328</cite> [<a href="https://doi.org/10.1002/acn3.51328" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8045954/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33739616/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Clin%20Transl%20Neurol.&amp;title=Hereditary%20transthyretin%20amyloidosis%20in%20mainland%20China:%20a%20unicentric%20retrospective%20study&amp;author=K%20Du&amp;author=F%20Li&amp;author=H%20Wang&amp;author=Y%20Miao&amp;author=H%20Lv&amp;volume=8&amp;publication_year=2021&amp;pages=831-41&amp;pmid=33739616&amp;doi=10.1002/acn3.51328&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>Bruno M, Castano A, Burton A, Grodin JL. Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges. Heart Fail Rev. (2021) 26:35–45. 10.1007/s10741-020-10010-8</cite> [<a href="https://doi.org/10.1007/s10741-020-10010-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7769788/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32794090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heart%20Fail%20Rev.&amp;title=Transthyretin%20amyloid%20cardiomyopathy%20in%20women:%20frequency,%20characteristics,%20and%20diagnostic%20challenges&amp;author=M%20Bruno&amp;author=A%20Castano&amp;author=A%20Burton&amp;author=JL%20Grodin&amp;volume=26&amp;publication_year=2021&amp;pages=35-45&amp;pmid=32794090&amp;doi=10.1007/s10741-020-10010-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>Damy T, Kristen AV, Suhr OB, Maurer MS, Plante-Bordeneuve V, Yu CR, et al. Transthyretin cardiac amyloidosis in continental western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS). Eur Heart J. (2019). 10.1093/eurheartj/ehz173</cite> [<a href="https://doi.org/10.1093/eurheartj/ehz173" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8825236/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30938420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J.&amp;title=Transthyretin%20cardiac%20amyloidosis%20in%20continental%20western%20Europe:%20an%20insight%20through%20the%20Transthyretin%20Amyloidosis%20Outcomes%20Survey%20(THAOS)&amp;author=T%20Damy&amp;author=AV%20Kristen&amp;author=OB%20Suhr&amp;author=MS%20Maurer&amp;author=V%20Plante-Bordeneuve&amp;publication_year=2019&amp;pmid=30938420&amp;doi=10.1093/eurheartj/ehz173&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>Batra J, Rosenblum H, Defilippis EM, Griffin JM, Saith SE, Gamino D, et al. Sex differences in the phenotype of transthyretin cardiac amyloidosis due to val122ile mutation: insights from noninvasive pressure-volume analysis. J Card Fail. (2021) 27:67–74. 10.1016/j.cardfail.2020.08.007</cite> [<a href="https://doi.org/10.1016/j.cardfail.2020.08.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7869136/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32829019/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Card%20Fail.&amp;title=Sex%20differences%20in%20the%20phenotype%20of%20transthyretin%20cardiac%20amyloidosis%20due%20to%20val122ile%20mutation:%20insights%20from%20noninvasive%20pressure-volume%20analysis&amp;author=J%20Batra&amp;author=H%20Rosenblum&amp;author=EM%20Defilippis&amp;author=JM%20Griffin&amp;author=SE%20Saith&amp;volume=27&amp;publication_year=2021&amp;pages=67-74&amp;pmid=32829019&amp;doi=10.1016/j.cardfail.2020.08.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. (2019) 73:2872–91. 10.1016/j.jacc.2019.04.003</cite> [<a href="https://doi.org/10.1016/j.jacc.2019.04.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6724183/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31171094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Coll%20Cardiol.&amp;title=Transthyretin%20amyloid%20cardiomyopathy:%20JACC%20state-of-the-art%20review&amp;author=FL%20Ruberg&amp;author=M%20Grogan&amp;author=M%20Hanna&amp;author=JW%20Kelly&amp;author=MS%20Maurer&amp;volume=73&amp;publication_year=2019&amp;pages=2872-91&amp;pmid=31171094&amp;doi=10.1016/j.jacc.2019.04.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid. (2003) 10:160–84. 10.3109/13506120308998998</cite> [<a href="https://doi.org/10.3109/13506120308998998" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14640030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid.&amp;title=Tabulation%20of%20human%20transthyretin%20(TTR)%20variants,%202003&amp;author=LH%20Connors&amp;author=A%20Lim&amp;author=T%20Prokaeva&amp;author=VA%20Roskens&amp;author=CE%20Costello&amp;volume=10&amp;publication_year=2003&amp;pages=160-84&amp;pmid=14640030&amp;doi=10.3109/13506120308998998&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>Connors LH, Theberge R, Skare J, Costello CE, Falk RH, Skinner M, et al. New transthyretin variant (Ser23Asn) associated with familial amyloidosis in a Portuguese patient. Amyloid. (1999) 6:114–8. 10.3109/13506129909007311</cite> [<a href="https://doi.org/10.3109/13506129909007311" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10439117/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid.&amp;title=New%20transthyretin%20variant%20(Ser23Asn)%20associated%20with%20familial%20amyloidosis%20in%20a%20Portuguese%20patient&amp;author=LH%20Connors&amp;author=R%20Theberge&amp;author=J%20Skare&amp;author=CE%20Costello&amp;author=RH%20Falk&amp;volume=6&amp;publication_year=1999&amp;pages=114-8&amp;pmid=10439117&amp;doi=10.3109/13506129909007311&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>Ueno S, Uemichi T, Takahashi N, Soga F, Yorifuji S, Tarui S. Two novel variants of transthyretin identified in Japanese cases with familial amyloidotic polyneuropathy: transthyretin (Glu42 to Gly) and transthyretin (Ser50 to Arg). Biochem Biophys Res Commun. (1990) 169:1117–21. 10.1016/0006-291X(90)92011-N</cite> [<a href="https://doi.org/10.1016/0006-291X(90)92011-N" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2363717/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20Biophys%20Res%20Commun.&amp;title=Two%20novel%20variants%20of%20transthyretin%20identified%20in%20Japanese%20cases%20with%20familial%20amyloidotic%20polyneuropathy:%20transthyretin%20(Glu42%20to%20Gly)%20and%20transthyretin%20(Ser50%20to%20Arg)&amp;author=S%20Ueno&amp;author=T%20Uemichi&amp;author=N%20Takahashi&amp;author=F%20Soga&amp;author=S%20Yorifuji&amp;volume=169&amp;publication_year=1990&amp;pages=1117-21&amp;pmid=2363717&amp;doi=10.1016/0006-291X(90)92011-N&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>Pelo E, Da Prato L, Ciaccheri M, Castelli G, Gori F, Pizzi A, et al. Familial amyloid polyneuropathy with genetic anticipation associated to a gly47glu transthyretin variant in an Italian kindred. Amyloid. (2002) 9:35–41. 10.3109/13506120209072443</cite> [<a href="https://doi.org/10.3109/13506120209072443" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12000196/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid.&amp;title=Familial%20amyloid%20polyneuropathy%20with%20genetic%20anticipation%20associated%20to%20a%20gly47glu%20transthyretin%20variant%20in%20an%20Italian%20kindred&amp;author=E%20Pelo&amp;author=L%20Da%20Prato&amp;author=M%20Ciaccheri&amp;author=G%20Castelli&amp;author=F%20Gori&amp;volume=9&amp;publication_year=2002&amp;pages=35-41&amp;pmid=12000196&amp;doi=10.3109/13506120209072443&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>Long D, Zeng J, Wu LQ, Tang LS, Wang HL, Wang H. Vitreous amyloidosis in two large mainland Chinese kindreds resulting from transthyretin variant Lys35Thr and Leu55Arg. Ophthalmic Genet. (2012) 33:28–33. 10.3109/13816810.2011.599356</cite> [<a href="https://doi.org/10.3109/13816810.2011.599356" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21843040/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ophthalmic%20Genet.&amp;title=Vitreous%20amyloidosis%20in%20two%20large%20mainland%20Chinese%20kindreds%20resulting%20from%20transthyretin%20variant%20Lys35Thr%20and%20Leu55Arg&amp;author=D%20Long&amp;author=J%20Zeng&amp;author=LQ%20Wu&amp;author=LS%20Tang&amp;author=HL%20Wang&amp;volume=33&amp;publication_year=2012&amp;pages=28-33&amp;pmid=21843040&amp;doi=10.3109/13816810.2011.599356&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>Saraiva MJ. Transthyretin mutations in health and disease. Hum Mutat. (1995) 5:191–6.</cite> [<a href="https://doi.org/10.1002/humu.1380050302" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7599630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat.&amp;title=Transthyretin%20mutations%20in%20health%20and%20disease&amp;author=MJ%20Saraiva&amp;volume=5&amp;publication_year=1995&amp;pages=191-6&amp;pmid=7599630&amp;doi=10.1002/humu.1380050302&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>Shiomi K, Nakazato M, Matsukura S, Ohnishi A, Hatanaka H, Tsuji S, et al. A basic transthyretin variant (Glu61–&gt;Lys) causes familial amyloidotic polyneuropathy: protein and DNA sequencing and PCR-induced mutation restriction analysis. Biochem Biophys Res Commun. (1993) 194:1090–6. 10.1006/bbrc.1993.1933</cite> [<a href="https://doi.org/10.1006/bbrc.1993.1933" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8352764/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20Biophys%20Res%20Commun.&amp;title=A%20basic%20transthyretin%20variant%20(Glu61%E2%80%93&gt;Lys)%20causes%20familial%20amyloidotic%20polyneuropathy:%20protein%20and%20DNA%20sequencing%20and%20PCR-induced%20mutation%20restriction%20analysis&amp;author=K%20Shiomi&amp;author=M%20Nakazato&amp;author=S%20Matsukura&amp;author=A%20Ohnishi&amp;author=H%20Hatanaka&amp;volume=194&amp;publication_year=1993&amp;pages=1090-6&amp;pmid=8352764&amp;doi=10.1006/bbrc.1993.1933&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>Holmgren G, Hellman U, Anan I, Lundgren HE, Jonasson J, Stafberg C, et al. Cardiomyopathy in Swedish patients with the Gly53Glu and His88Arg transthyretin variants. Amyloid. (2005) 12:184–8. 10.1080/13506120500223126</cite> [<a href="https://doi.org/10.1080/13506120500223126" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16194874/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid.&amp;title=Cardiomyopathy%20in%20Swedish%20patients%20with%20the%20Gly53Glu%20and%20His88Arg%20transthyretin%20variants&amp;author=G%20Holmgren&amp;author=U%20Hellman&amp;author=I%20Anan&amp;author=HE%20Lundgren&amp;author=J%20Jonasson&amp;volume=12&amp;publication_year=2005&amp;pages=184-8&amp;pmid=16194874&amp;doi=10.1080/13506120500223126&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>Tachibana N, Tokuda T, Yoshida K, Taketomi T, Nakazato M, Li YF, et al. Usefulness of MALDI/TOF mass spectrometry of immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy. Amyloid. (1999) 6:282–8. 10.3109/13506129909007341</cite> [<a href="https://doi.org/10.3109/13506129909007341" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10611950/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid.&amp;title=Usefulness%20of%20MALDI/TOF%20mass%20spectrometry%20of%20immunoprecipitated%20serum%20variant%20transthyretin%20in%20the%20diagnosis%20of%20familial%20amyloid%20polyneuropathy&amp;author=N%20Tachibana&amp;author=T%20Tokuda&amp;author=K%20Yoshida&amp;author=T%20Taketomi&amp;author=M%20Nakazato&amp;volume=6&amp;publication_year=1999&amp;pages=282-8&amp;pmid=10611950&amp;doi=10.3109/13506129909007341&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>Hsu HC, Liao MF, Hsu JL, Lo AL, Kuo HC Lyu RK, et al. Phenotypic expressions of hereditary Transthyretin Ala97Ser related Amyloidosis (ATTR) in Taiwanese. BMC Neurol. (2017) 17:178. 10.1186/s12883-017-0957-4</cite> [<a href="https://doi.org/10.1186/s12883-017-0957-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5590125/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28882124/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Neurol.&amp;title=Phenotypic%20expressions%20of%20hereditary%20Transthyretin%20Ala97Ser%20related%20Amyloidosis%20(ATTR)%20in%20Taiwanese&amp;author=HC%20Hsu&amp;author=MF%20Liao&amp;author=JL%20Hsu&amp;author=AL%20Lo&amp;author=RK%20Kuo%20HC%20Lyu&amp;volume=17&amp;publication_year=2017&amp;pages=178&amp;pmid=28882124&amp;doi=10.1186/s12883-017-0957-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>Low SC, Tan CY, Md Sari NA, Ahmad-Annuar A, Wong KT, Lin KP, et al. Ala97Ser mutation is common among ethnic Chinese Malaysians with transthyretin familial amyloid polyneuropathy. Amyloid. (2019) 26:7–8. 10.1080/13506129.2019.1582479</cite> [<a href="https://doi.org/10.1080/13506129.2019.1582479" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31343308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid.&amp;title=Ala97Ser%20mutation%20is%20common%20among%20ethnic%20Chinese%20Malaysians%20with%20transthyretin%20familial%20amyloid%20polyneuropathy&amp;author=SC%20Low&amp;author=CY%20Tan&amp;author=NA%20Md%20Sari&amp;author=A%20Ahmad-Annuar&amp;author=KT%20Wong&amp;volume=26&amp;publication_year=2019&amp;pages=7-8&amp;pmid=31343308&amp;doi=10.1080/13506129.2019.1582479&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>Liu YT, Lee YC, Yang CC, Chen ML, Lin KP. Transthyretin Ala97Ser in Chinese-Taiwanese patients with familial amyloid polyneuropathy: genetic studies and phenotype expression. J Neurol Sci. (2008) 267:91–9. 10.1016/j.jns.2007.10.011</cite> [<a href="https://doi.org/10.1016/j.jns.2007.10.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18022643/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neurol%20Sci.&amp;title=Transthyretin%20Ala97Ser%20in%20Chinese-Taiwanese%20patients%20with%20familial%20amyloid%20polyneuropathy:%20genetic%20studies%20and%20phenotype%20expression&amp;author=YT%20Liu&amp;author=YC%20Lee&amp;author=CC%20Yang&amp;author=ML%20Chen&amp;author=KP%20Lin&amp;volume=267&amp;publication_year=2008&amp;pages=91-9&amp;pmid=18022643&amp;doi=10.1016/j.jns.2007.10.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>Chao CC, Huang CM, Chiang HH, Luo KR, Kan HW, Yang NC, et al. Sudomotor innervation in transthyretin amyloid neuropathy: Pathology and functional correlates. Ann Neurol. (2015) 78:272–83. 10.1002/ana.24438</cite> [<a href="https://doi.org/10.1002/ana.24438" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5034810/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25973863/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Neurol.&amp;title=Sudomotor%20innervation%20in%20transthyretin%20amyloid%20neuropathy:%20Pathology%20and%20functional%20correlates&amp;author=CC%20Chao&amp;author=CM%20Huang&amp;author=HH%20Chiang&amp;author=KR%20Luo&amp;author=HW%20Kan&amp;volume=78&amp;publication_year=2015&amp;pages=272-83&amp;pmid=25973863&amp;doi=10.1002/ana.24438&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>Castiglione V, Franzini M, Aimo A, Carecci A, Lombardi CM, Passino C, et al. Use of biomarkers to diagnose and manage cardiac amyloidosis. Eur J Heart Fail. (2021) 23:217–30. 10.1002/ejhf.2113</cite> [<a href="https://doi.org/10.1002/ejhf.2113" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33527656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Heart%20Fail.&amp;title=Use%20of%20biomarkers%20to%20diagnose%20and%20manage%20cardiac%20amyloidosis&amp;author=V%20Castiglione&amp;author=M%20Franzini&amp;author=A%20Aimo&amp;author=A%20Carecci&amp;author=CM%20Lombardi&amp;volume=23&amp;publication_year=2021&amp;pages=217-30&amp;pmid=33527656&amp;doi=10.1002/ejhf.2113&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis. a position statement of the European Society of cardiology working group on myocardial and pericardial diseases. Eur J Heart Fail. (2021) 23:512–26. 10.1002/ejhf.2140</cite> [<a href="https://doi.org/10.1002/ejhf.2140" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33826207/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Heart%20Fail.&amp;title=Diagnosis%20and%20treatment%20of%20cardiac%20amyloidosis.%20a%20position%20statement%20of%20the%20European%20Society%20of%20cardiology%20working%20group%20on%20myocardial%20and%20pericardial%20diseases&amp;author=P%20Garcia-Pavia&amp;author=C%20Rapezzi&amp;author=Y%20Adler&amp;author=M%20Arad&amp;author=C%20Basso&amp;volume=23&amp;publication_year=2021&amp;pages=512-26&amp;pmid=33826207&amp;doi=10.1002/ejhf.2140&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>Suhr OB, Herlenius G, Friman S, Ericzon BG. Liver transplantation for hereditary transthyretin amyloidosis. Liver Transpl. (2000) 6:263–76. 10.1053/lv.2000.6145</cite> [<a href="https://doi.org/10.1053/lv.2000.6145" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10827225/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Liver%20Transpl.&amp;title=Liver%20transplantation%20for%20hereditary%20transthyretin%20amyloidosis&amp;author=OB%20Suhr&amp;author=G%20Herlenius&amp;author=S%20Friman&amp;author=BG%20Ericzon&amp;volume=6&amp;publication_year=2000&amp;pages=263-76&amp;pmid=10827225&amp;doi=10.1053/lv.2000.6145&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<span class="label">31.</span><cite>Carvalho A, Rocha A, Lobato L. Liver transplantation in transthyretin amyloidosis: issues and challenges. Liver Transpl. (2015) 21:282–92. 10.1002/lt.24058</cite> [<a href="https://doi.org/10.1002/lt.24058" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25482846/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Liver%20Transpl.&amp;title=Liver%20transplantation%20in%20transthyretin%20amyloidosis:%20issues%20and%20challenges&amp;author=A%20Carvalho&amp;author=A%20Rocha&amp;author=L%20Lobato&amp;volume=21&amp;publication_year=2015&amp;pages=282-92&amp;pmid=25482846&amp;doi=10.1002/lt.24058&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<span class="label">32.</span><cite>Liepnieks JJ, Zhang LQ, Benson MD. Progression of transthyretin amyloid neuropathy after liver transplantation. Neurology. (2010) 75:324–7. 10.1212/WNL.0b013e3181ea15d4</cite> [<a href="https://doi.org/10.1212/WNL.0b013e3181ea15d4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2918887/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20660862/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology.&amp;title=Progression%20of%20transthyretin%20amyloid%20neuropathy%20after%20liver%20transplantation&amp;author=JJ%20Liepnieks&amp;author=LQ%20Zhang&amp;author=MD%20Benson&amp;volume=75&amp;publication_year=2010&amp;pages=324-7&amp;pmid=20660862&amp;doi=10.1212/WNL.0b013e3181ea15d4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/9271707/bin/Table_1.DOCX" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (15.6KB, DOCX) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/9271707/bin/Table_2.DOCX" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (15.2KB, DOCX) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The original contributions presented in the study are included in the article/<a href="#SM1" class="usa-link">Supplementary Materials</a>, further inquiries can be directed to the corresponding author.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Frontiers in Cardiovascular Medicine are provided here courtesy of <strong>Frontiers Media SA</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3389/fcvm.2022.900313"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/fcvm-09-900313.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (814.9 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/9271707/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/9271707/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9271707%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9271707/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC9271707/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC9271707/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/35833187/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC9271707/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/35833187/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC9271707/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/9271707/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="YJ4XI7OVNZU99FZDQX0oAPEVaq4RiYm8ZsREbSc7Kl9Ft8iY4b54ot6vVekrVy3M">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
